BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28448960)

  • 1. Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.
    Saab J; Zia H; Mathew S; Kluk M; Narula N; Fernandes H
    Transl Oncol; 2017 Jun; 10(3):442-449. PubMed ID: 28448960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic and molecular approach to staging of multiple lung nodules.
    Schneider F; Dacic S
    Transl Lung Cancer Res; 2017 Oct; 6(5):540-549. PubMed ID: 29114470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
    Rafael OC; Lazzaro R; Hasanovic A
    Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience.
    Asmar R; Sonett JR; Singh G; Mansukhani MM; Borczuk AC
    J Thorac Oncol; 2017 Oct; 12(10):1524-1535. PubMed ID: 28647671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of
    Tan B; Jiang X; Wang R; Tang C; Liu S; Wu X; Xia L; Yu X; Yang Z
    Front Oncol; 2019; 9():1319. PubMed ID: 31828041
    [No Abstract]   [Full Text] [Related]  

  • 8. [HRCT features differentiate synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases].
    Zhou LN; Wu N; Zhao SJ; Yang L; Wang YL; Wang RB; Yang SX
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):449-455. PubMed ID: 32575939
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
    Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
    Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.
    Mansuet-Lupo A; Barritault M; Alifano M; Janet-Vendroux A; Zarmaev M; Biton J; Velut Y; Le Hay C; Cremer I; Régnard JF; Fournel L; Rance B; Wislez M; Laurent-Puig P; Herbst R; Damotte D; Blons H
    J Thorac Oncol; 2019 May; 14(5):844-856. PubMed ID: 30721797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status.
    Linhas R; Tente D; Dias M; Barroso A
    Respir Med Case Rep; 2017; 22():15-18. PubMed ID: 28626632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.
    Ericson-Lindquist K; Johansson A; Levéen P; Elmberger G; Jönsson G; Staaf J; Brunnström H
    Diagn Pathol; 2017 Mar; 12(1):31. PubMed ID: 28347348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Sequencing Facilitated Diagnosis of an Uncommon Patient Harboring Both Multiple Primary and Intrapulmonary Metastatic Lung Cancer: A Case Report.
    Li H; Dong S; Zhang D; Guo Z; Li C; Xiang J; Zou X; Yan L; Sun Y; Li W
    Onco Targets Ther; 2021; 14():3455-3459. PubMed ID: 34079290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
    Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
    Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.
    Pareja F; Crapanzano JP; Mansukhani MM; Bulman WA; Saqi A
    Cancer Cytopathol; 2015 Mar; 123(3):162-70. PubMed ID: 25557162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
    Song Y; Zhou J; Zhao X; Zhang Y; Xu X; Zhang D; Pang J; Bao H; Ji Y; Zhan M; Wang Y; Ou Q; Hu J
    Front Oncol; 2023; 13():1237308. PubMed ID: 37799479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.